Antithrombin 2026-11-05
Antithrombin is a blood plasma serpin that inhibits coagulation serine proteases, including factor Xa. Its activity is enhanced by binding an appropriate sequence in heparin. The inhibitory protein and its activating carbohydrate partner therefore play different molecular roles.[ref]
In a 1983 experiment, investigators synthesized related four- and five-sugar fragments and checked their structures with nuclear magnetic resonance. The tested five-sugar fragment bound antithrombin and enhanced inhibition of factor Xa; the tested four-sugar fragment did neither in that comparison.[ref]
A 1997 structural study connected binding to changes in the main beta sheet and exposure of the reactive-center loop. This supplied a structural explanation for activation rather than merely another measurement of binding.[ref] The sequence-specific comparison matters: counting five sugars does not guarantee that an arbitrary five-sugar chain has the same activity.
Blood plasma Created 2026-10-31 Updated 2026-11-05
Blood plasma is the fluid component of blood in which cells are suspended. It contains water, proteins and dissolved substances, including components of coagulation. Serum is obtained after clotting and therefore is not compositionally identical to plasma.
Blood product Created 2026-10-31 Updated 2026-11-05
A preparation derived from donated blood, such as a cellular component or blood plasma-derived material. Product identity determines its biological purpose; the phrase does not describe one uniform replacement fluid.
Blood serum 2026-11-05
Blood serum is the liquid recovered after blood has clotted and the clot and blood cells have been separated. In particular, fibrinogen has been converted into the fibrin network of the clot. Blood plasma is instead the liquid portion of blood whose clotting has been prevented, so it retains fibrinogen.[ref]
A two-tube comparison makes the distinction concrete. Allow one sample to clot before centrifugation; prevent clotting in the other and then centrifuge it. Both yield liquid fractions, but the preparations have undergone different biochemical processes. Blood serum still contains many proteins, including antibodies; it is not a protein-free version of blood. Consequently an assay validated for one specimen type should not be interpreted as though sample preparation were irrelevant.
Capillary bed 2026-11-05
A capillary bed is a network of capillaries connecting arterioles to venules. It spreads blood flow across many small vessels, providing a large exchange surface between blood plasma and surrounding interstitial fluid. Upstream vascular resistance and the arrangement of the network affect how much blood reaches that surface.[ref]
The aggregate cross-sectional area helps explain why narrow individual vessels need not imply rapid transit. In an ideal model with identical open capillaries of radius sharing total volumetric flow rate equally, the mean axial velocity is
At fixed and , doubling halves . This is a conservation of mass calculation; actual exchange also depends on the wall, the exchanged substance and uneven flow through real networks.
The endothelial glycocalyx is one such wall feature. R. H. Adamson and colleagues found that effective oncotic pressure still opposed filtration when bulk albumin concentrations on both sides of rat microvessels were matched. Their imaging and modelling implicated the local environment near the endothelial glycocalyx, showing why bulk interstitial fluid measurements alone do not specify the filtration barrier.[ref]
Fibrinogen 2026-11-05
Fibrinogen is a soluble blood plasma protein that supplies the building material for fibrin during coagulation. Thrombin cleaves small fibrinopeptides from fibrinogen, exposing sites that allow the resulting fibrin units to associate. The cleavage is a chemical trigger for assembly; forming the network also requires interactions between different protein molecules.[ref]
A single-molecule experiment used optical tweezers to bring prepared protein partners together and measure their separation forces. Exposing the “A” binding knobs in fibrin produced strong specific interactions with complementary sites in fibrinogen or its end fragment. A competing peptide that mimicked the exposed knob suppressed those interactions, providing a control for binding-site specificity.[ref]
This explains how a solution of precursors can become a connected polymer network after limited proteolysis. The measurements concern defined molecular contacts; a complete clot's mechanics additionally depend on how many such contacts form and how the fibrin network is organized.
G. L. Hammond 2026-11-05
G. L. Hammond investigated how circulating binding proteins influence access to steroid hormones. A 1990 study examined corticosteroid-binding globulin, a blood plasma protein that binds cortisol, and its interaction with neutrophil elastase.[ref]
In the assay, neutrophil elastase cleaved corticosteroid-binding globulin near its terminal region and released more than 80% of its bound cortisol. The cleavage did not inhibit the enzyme. The work supplied a molecular mechanism by which a hormone-binding carrier can change local hormone availability, while the proposed physiological delivery role requires distinguishing an experimental mechanism from its magnitude in living tissue.[ref]
Figure 1.
G. L. Hammond
. Portrait linked from the BC Children's Hospital Research Institute profile, which identifies his research on steroid-binding proteins.
Glomerular filtration 2026-11-05
Glomerular filtration is transfer of water and filterable solutes from glomerular blood plasma across the glomerular filtration barrier into the capsular space. Most blood cells and much of the plasma protein remain in the circulation. The resulting fluid begins the tubular pathway; its composition can subsequently change through reabsorption and secretion, so filtration is not identical to final renal excretion.
A simplified pressure model writes the filtered volumetric flow rate as
where combines hydraulic permeability and filtering area, denotes hydrostatic pressure, denotes oncotic pressure, and subscripts refer to glomerular capillary and capsular fluid. Here the pressure terms represent effective averages, with freely transmitted water pressure and a simplified protein-retention assumption. Actual pressures and concentrations vary along a capillary.[ref]
For a hypothetical calculation, take , , and , all in . The net driving pressure is . If , then . These chosen values illustrate the model, rather than specifying normal human measurements. Increasing receiving-space pressure reduces filtration even if capillary pressure stays fixed.
In 1971, investigators used rats with unusually accessible surface glomeruli and servo-null micropipette measurements to test these driving forces directly. Combining pressure measurements with single-nephron filtration measurements made it possible to estimate the barrier's hydraulic behavior, instead of inferring it from final urine alone.[ref]
Gonadotropin-releasing hormone (GnRH) is a peptide hormone secreted by hypothalamic neurons that regulates release of luteinizing hormone and follicle-stimulating hormone from gonadotrophs in the anterior pituitary. The hypophyseal portal system carries this upstream signal directly to its pituitary target.
The releasing factor and the released products are separate hormones. That distinction was made experimentally by testing hypothalamic material for its ability to stimulate pituitary output. A 1971 report by Andrew Schally and collaborators described a purified releasing factor that stimulated both luteinizing hormone and follicle-stimulating hormone, helping establish a common hypothalamic input to the two responses.[ref]
Timing is part of the signal. In the 1982 sheep study by Iain J. Clarke and James T. Cummins, GnRH pulses measured in portal blood plasma were synchronous with LH pulses measured downstream in peripheral blood plasma.[ref] The hypophyseal portal system article describes that measurement geometry in more detail.
A time-averaged concentration therefore discards information about the pattern of hormone delivery. The experiment measured both the upstream signal and its pituitary output, linking a chemical identity to a physiological rhythm.
Hypophyseal portal system 2026-11-05
The hypophyseal portal system is the vascular route carrying regulatory hormones from the hypothalamus directly to the anterior pituitary. Hypothalamic neurons release their chemical signals into a first network of capillaries. Hypophyseal portal veins then carry that blood to a second capillary network alongside the secretory biological cells of the anterior pituitary. This is a portal system: two capillary beds connected in sequence.[ref]
The route makes a small local secretion an effective input to another gland. In an ideal steady mass balance, let a hormone enter blood plasma at molar rate , with plasma volumetric flow rate . Ignoring removal and assuming complete mixing, the downstream molar concentration is
This is a delivery model, not a universal physiological constant: changing secretion, flow, extraction or mixing changes the resulting signal. It explains the benefit of reaching the target before whole-body dilution.
A 1982 experiment by Iain J. Clarke and James T. Cummins sampled this upstream communication directly in conscious ovariectomized sheep, using a procedure that maintained pituitary function. They measured gonadotropin-releasing hormone (GnRH) in portal blood plasma and luteinizing hormone (LH) in peripheral jugular blood plasma. The secretory pulses were synchronous: each observed LH episode was linked to a pulsatile GnRH discharge through the portal network.[ref]
Sampling the two locations matters. The portal measurement detects the hypothalamic message before it reaches the anterior pituitary; the peripheral measurement detects the pituitary's output. A single downstream hormone trace would not reveal both sides of that timing relationship.
Hypophyseal portal vein 2026-11-05
A hypophyseal portal vein is a vein connecting the first and second capillary networks of the hypophyseal portal system. The main route carries blood from the median eminence region of the hypothalamus, down the pituitary stalk, to the anterior pituitary. It delivers hypothalamic hormones before their dilution in the wider circulation.[ref]
The word “portal” describes the route: blood leaving one capillary bed reaches another capillary bed before returning to the heart. Here the first bed receives a regulatory message and the second delivers it to responding biological cells. A hypophyseal portal vein is therefore an interconnecting segment, rather than the entire hypophyseal portal system.
A useful example is a pulse of gonadotropin-releasing hormone. In conscious sheep, simultaneous sampling of portal and peripheral blood plasma linked portal GnRH pulses with peripheral luteinizing hormone episodes. Sampling the hypophyseal portal vein route accesses the incoming hypothalamic signal; peripheral sampling detects the resulting pituitary output. That distinction is why the sampling location is part of the experiment, not just a convenient place to draw blood.[ref]
Interstitial fluid 2026-11-05
Interstitial fluid is the extracellular fluid between the body's cells, outside the circulating blood plasma. It provides the immediate fluid environment through which many dissolved substances move between capillaries and cells. Fluid entering lymphatic vessels becomes lymph, so exchange with blood and drainage through the lymphatic system jointly influence its volume.[ref]
A simplified volume balance is
where is net filtration into the interstitial compartment and is lymphatic outflow. In an illustrative compartment, inflow and outflow of leave volume steady even though fluid continues moving. If inflow becomes while outflow stays , the compartment gains each minute. A steady volume therefore does not imply an absence of exchange.
The barrier's microscopic structure also matters. In 2004 experiments, researchers perfused rat microvessels with albumin solution and adjusted albumin around the vessel. A substantial effective oncotic pressure still opposed filtration even when bulk tissue and vessel concentrations matched. Imaging and modeling supported a protected concentration region near the endothelial glycocalyx. The result shows why bulk interstitial fluid composition alone does not fully specify the forces across the vessel wall.[ref]
Luteinizing hormone 2026-11-05
Luteinizing hormone (LH) is a glycoprotein gonadotropin released by gonadotrophs in the anterior pituitary under control of gonadotropin-releasing hormone. It participates in ovulation and formation of the corpus luteum, and promotes testosterone production in the testis. The hormone's output is regulated within interacting pituitary and gonadal feedback pathways.[ref]
The shape of a LH surge can be investigated by measuring several signals through time. In 1983, J. D. Hoff and colleagues studied five women with hormone measurements every two hours for five consecutive days around midcycle. They compared estradiol, progesterone and gonadotropin trajectories, finding an abrupt onset of the LH and follicle-stimulating hormone surges in temporal association with the estradiol peak.[ref]
The report included a doubling of LH within a two-hour interval at surge onset. Such a change illustrates why sampling frequency matters: coarse measurements can blur an abrupt transition or shift the apparent ordering of events. The study describes a measured cohort pattern; it does not turn one isolated hormone measurement into a complete account of the cycle.
The relation to GnRH can also be probed by paired portal and peripheral blood plasma measurements. The hypophyseal portal system makes those two locations physiologically different: one carries the hypothalamic input, while the other records the pituitary's released output.
Margaret Mylle 2026-11-05
Margaret Mylle was a researcher in the physiology of the kidney and a long-term collaborator of Carl W. Gottschalk. Their work used renal micropuncture to investigate fluid conditions within individual parts of the nephron, rather than inferring every process from the final urine.[ref]
Their 1959 study compared osmolality in samples from renal tubules, collecting ducts, the Loop of Henle and small renal vessels. Oil-filled glass micropipettes collected tiny fluid samples, whose freezing-point depression supplied a concentration measurement.[ref]
The illuminating feature is the specificity of the sampling site. A high concentration in final urine does not identify where concentration developed. Comparing local fluid with blood plasma, and with fluid elsewhere in the kidney, turns an overall output into a spatial test of a physiological mechanism. The joint experiments helped connect microscopic anatomy with the concentrating function of the whole organ.
The significance of glycosuria and albuminuria depends on persistence, amount, mechanism and accompanying findings. The older words “sugar” and “albumen” do not guarantee that a nineteenth-century test identified one particular molecule.
For urinary sugar, distinguish the following situations:
Modern glucose-specific assays and concurrent blood glucose measurements distinguish excess filtered load from reduced recovery.[ref][ref]
For “albumen”, the principal pathological groups are injury to the glomerular filtration barrier in glomerulonephritis, renal amyloidosis, diabetic kidney disease and other glomerular diseases; changes associated with heart failure and renal venous congestion; and pregnancy-associated injury such as pre-eclampsia. Fever and severe exertion may produce transient proteinuria, while orthostatic proteinuria can disappear during recumbency. Impaired tubular recovery chiefly increases smaller urinary proteins; it should not automatically be called a selective loss of serum albumin.[ref]
A collected specimen can also receive blood plasma proteins from haematuria or inflammatory material below the filtering apparatus. Moreover, immunoglobulin light chains in multiple myeloma can give a positive general protein test without being serum albumin. Historical heat and acid precipitation tested a physical property of material in a tube, not a modern molecular diagnosis.[ref][ref]
The diagnostic value consequently rises with reproducibility and coherent accompanying evidence. Persistent heavy albuminuria, especially with oedema and abnormal sediment, strongly suggests significant renal disease; red blood cell casts support a renal rather than merely lower-tract source of bleeding. Repeated urinalysis, sediment microscopy and a urine albumin-to-creatinine ratio help quantify and localize the problem.[ref] Coexisting glycosuria and albuminuria may reflect diabetes with renal injury, or another combination of mechanisms. Neither their coexistence nor either isolated result is sufficient to establish the whole diagnosis.
An albuminous urine specimen can reflect renal leakage, altered renal function, or added blood plasma proteins below the kidney. Finding serum albumin in urine identifies a phenomenon, not a single disease.
In the historical setting, the important group was the renal disorders gathered under Bright's disease: acute inflammatory disease, including that following scarlet fever, and chronic diseased or contracted kidneys. In current terms, glomerulonephritis damages the glomerular filtration barrier, permitting increased passage of serum albumin into the filtrate. Red blood cells and urinary casts may accompany the loss. Different modern glomerular diseases can produce the same finding; the nineteenth-century umbrella does not identify one modern microscopic diagnosis.[ref]
In renal amyloidosis, deposition in the glomeruli disrupts their filtering structure; heavy albuminuria and nephrotic syndrome may result. Diabetic kidney disease and hypertensive kidney disease provide further modern examples of chronic injury to the filtering apparatus. These modern classifications distinguish mechanisms.[ref]
The heart failure group includes renal venous congestion and impaired effective kidney perfusion. Altered pressures and injury to the filtering apparatus can increase albuminuria; an albuminous specimen does not by itself prove destructive nephritis. Fever and severe acute illness can also produce transient proteinuria through reversible changes in renal function. In pre-eclampsia, injury to the filtering apparatus, including glomerular endotheliosis, can cause albuminuria.[ref] Pregnancy alone does not make albuminuria normal, and pressure from a gravid uterus is not an adequate general explanation of this disorder.[ref]
Finally distinguish renal loss from addition below the filtering apparatus. Haematuria, pyelonephritis, cystitis and contamination by inflammatory or genital material can add blood plasma proteins, including serum albumin, to a collected specimen. Microscopy and a clean sample help distinguish these possibilities. Tubulointerstitial nephritis reduces proximal tubule recovery of filtered proteins, but predominantly causes loss of smaller proteins. Likewise, overflow of immunoglobulin light chains in multiple myeloma is proteinuria, not necessarily albuminuria. Haematuria alone can contribute blood plasma proteins, so modest protein positivity need not locate the bleeding in the kidney.[ref] The distinction matters because an old protein-precipitation test did not identify the molecular species.[ref]
A useful diagnostic comparison is repeated urinalysis, with microscopy of the sediment and a modern urine albumin-to-creatinine ratio. Persistence, red blood cell casts, and the clinical setting distinguish sustained glomerular disease from a transient change or lower-tract addition. A positive protein test alone cannot make that distinction.[ref]
Plasma protein Created 2026-10-31 Updated 2026-11-05
A plasma protein is a protein present in blood plasma. Transport, immune functions, coagulation and osmotic effects are among their different roles. Total protein concentration does not specify the amount or activity of any one component.
Renal glycosuria Created 2026-10-31 Updated 2026-11-05
Glycosuria arising from renal glucose-handling changes without the elevated blood plasma glucose ordinarily responsible for overflow. It can be isolated or part of a broader tubular disorder.[ref]
Renal medulla 2026-11-05
The renal medulla is the inner region of the kidney, lying beneath the renal cortex and organized into renal pyramids. It contains portions of the Loop of Henle, collecting ducts and the renal vasa recta. The arrangement supports the production of urine more concentrated than blood plasma.[ref]
Along the renal medulla, the surrounding fluid generally becomes more concentrated toward the renal papilla. Countercurrent multiplication involving the Loop of Henle helps establish this gradient; exchange in the renal vasa recta helps preserve it. A water-permeable collecting duct can then lose water by osmosis while passing through the concentrated surroundings.
In 1959, Carl W. Gottschalk and Margaret Mylle measured osmolality in tiny fluid samples collected by renal micropuncture. Oil-filled glass micropipettes sampled particular locations; freezing-point depression supplied a concentration measurement. Fluid from loop bends, collecting ducts and renal vasa recta at the same medullary level was similarly hyperosmotic. This supported a shared local concentrating environment and a countercurrent interpretation, rather than concentration occurring only inside one isolated tube.[ref]
The experiment connects location to function: a diagram showing a Loop of Henle merely bending back is incomplete without the measured concentration differences along the surrounding tissue.
Renal micropuncture 2026-11-05
Renal micropuncture is an experimental method for accessing tiny fluid compartments in a living kidney with a fine micropipette, usually under microscopy. It can sample a particular renal tubule or vessel instead of measuring only the final mixed urine. The sampling location turns a whole-organ observation into a spatial test of renal function.
In 1959, Carl W. Gottschalk and Margaret Mylle collected nanolitre-scale samples in oil-filled glass micropipettes and measured osmolality using freezing-point depression. Comparing loop bends, collecting ducts and renal vasa recta at corresponding medullary levels tested the countercurrent multiplication hypothesis directly. Position mattered as much as the concentration measurement.[ref]
An ideal freely filtered marker provides a quantitative example. Let its molar concentration in blood plasma be , its tubular concentration at a sampled site be , the initial single-nephron filtration flow be , and the remaining tubular flow be . At steady state, with no tubular gain or loss of marker, mass balance gives
If the hypothetical measured ratio is , one quarter of the initial fluid flow remains and three quarters has been reabsorbed upstream. The marker became concentrated without needing to be added along the tubule.
This interpretation depends on the marker assumptions and faithful sampling. Leakage, changing flow, evaporation or an incorrectly identified sampling site can change the answer. A final urine concentration alone cannot establish where along the nephron the inferred transport occurred.